Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2003
09/23/2003US6624317 Taxoid conjugates as antimitotic and antitumor agents
09/23/2003US6624314 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
09/23/2003US6624288 Conotoxins comprising cyclic peptides used as agonists of calcium channels blockers
09/23/2003US6624202 Inhibitors of copper-containing amine oxidases
09/23/2003US6624199 Prophylaxis and treatment of acne and acne related skin diseases with aminobenzophenones, and novel compounds effective in the treatment, as well as pharmaceutical preparations containing these compounds and dosage units
09/23/2003US6624187 Long wave length absorbing bacteriochlorin alkyl ether analogs
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624185 Drugs at least one lipid- or triglyceride-lowering active compound; and carriers for lipid metabolism
09/23/2003US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
09/23/2003US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624176 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors
09/23/2003US6624175 4-heterocyclic substituted quinoline derivative treats disorderes associated with pathogenic neurokinin-3 receptor, such as anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder or pain
09/23/2003US6624174 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624169 Urokinase inhibitors
09/23/2003US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can
09/23/2003US6624166 Pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1 beta protease activity in a mammal utilizing the compounds and compositions for enzyme inhibitors
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder
09/23/2003US6624161 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
09/23/2003US6624160 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/23/2003US6624159 Herpes virus
09/23/2003US6624157 Antitumor agents
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6624147 Inhibitors of prenylated pyrophosphate consuming enzymes
09/23/2003US6624144 Matrix metalloproteinase inhibitors and down-regulators
09/23/2003US6624142 Trimethyl lock based tetrapartate prodrugs
09/23/2003US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same
09/23/2003US6623934 For isolation of proteins that may be used to induce bone and/or cartilage or other connective tissue formation, and in wound healing and tissue repair
09/23/2003US6623738 Polypeptide consisting of amino acid sequence 2 or 4 which is not cross reactive with mouse, chick nor drosophila neuro-pilin-1
09/23/2003US6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
09/23/2003US6623472 Method for inducing therapeutically-effective proteins
09/23/2003CA2314865C Methods for preventing and treating mastitis
09/23/2003CA2281570C Composition for treating tumors containing shark cartilage extracts and anti-neoplastic agents
09/23/2003CA2275527C Novel heterocyclic substituted pyrrolidine amide derivatives
09/23/2003CA2244196C Dihydrobenzofuran compounds useful as anti-inflammatory agents
09/23/2003CA2218555C Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
09/23/2003CA2115442C Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist
09/23/2003CA2098122C Anti-atherosclerotic aryl compounds
09/23/2003CA2091651C Agent for suppresion and interception of mailard reaction
09/23/2003CA2085781C Bradykinin-antagonists for the treatment of acute pancreatitis
09/23/2003CA2066807C Contraception in female primates without affecting the menstrual cycle
09/23/2003CA2062973C Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia
09/19/2003WO2002072077A2 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/19/2003CA2457192A1 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/18/2003WO2003077159A1 Method of forming molecule function network
09/18/2003WO2003076639A1 Osteoclast differentiation inhibitors
09/18/2003WO2003076638A1 Angiogenesis inhibitors
09/18/2003WO2003076623A1 Cdc7-ASK KINASE COMPLEX, SUBSTRATE OF THE KINASE COMPLEX, ANTIBODY SPECIFIC TO THE SUBSTRATE, AND METHOD OF SCREENING COMPOUND CAPABLE OF INHIBITING Cdc7-ASK KINASE USING THE SAME
09/18/2003WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene
09/18/2003WO2003076613A1 Protein sustaining undifferentiated stem cells as such
09/18/2003WO2003076605A1 A method for producing recombinant viruses using site-specific recombination
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076475A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
09/18/2003WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/18/2003WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides
09/18/2003WO2003076458A2 Selective dipeptide inhibitors of kallikrein
09/18/2003WO2003076457A1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076445A2 Microtubule stabilizing compounds
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076442A1 Purine derivatives as kinase inhibitors
09/18/2003WO2003076439A2 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076429A2 Azepane derivatives and their use as atk1 inhibitors
09/18/2003WO2003076427A1 Quinazoline compounds useful in therapy
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076420A1 Cyclic amides
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003076414A2 Aryl substituted pyrimidines and the use thereof
09/18/2003WO2003076413A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
09/18/2003WO2003076412A1 Novel hairpin polyamide
09/18/2003WO2003076411A1 Process for producing optically active sulfoxide derivative
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076402A1 Therapeutic agent for pain
09/18/2003WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003WO2003076391A2 Urokinase inhibitors, production and use thereof
09/18/2003WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003WO2003075982A1 Multiple compartment bag assembly for dialysis fluid
09/18/2003WO2003075959A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
09/18/2003WO2003075958A1 Remedies for sex hormone-dependent disease
09/18/2003WO2003075957A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
09/18/2003WO2003075946A2 Treatment of type i diabetes mellitus using growth hormone antagonist
09/18/2003WO2003075935A1 Drugs containing riboflavin-type compounds
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075928A2 Stable pharmaceutical compositions
09/18/2003WO2003075926A1 Use of proton pump inhibitors for the treatment of airway disorders
09/18/2003WO2003075923A1 Vdac regulator
1 ... 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 ... 1564